Authors

Latest:

Dr. Kurtzberg on Long-term OS for Remestemcel-L in Pediatric Steroid-Refractory aGVHD

Joanne Kurtzberg, MD, discusses the long-term survival outcomes from an observational cohort study evaluating remestemcel-L in pediatric patients with steroid-refractory acute graft-vs-host disease.

Jonathan D. Cheng, MD

Latest:

Dr. Cheng on Advances With Immunotherapy-Based Combinations in Oncology

Jonathan D. Cheng, MD, discusses advances with immunotherapy-based combinations in oncology.

David J. Benjamin, MD

David J. Benjamin, MD, is a medical oncologist at Hoag Family Cancer Institute.

Latest:

Dr Benjamin on Using Real-World Data to Bridge Knowledge Gaps in Urothelial Cancer Care

David J. Benjamin, MD, expands on real-world studies to help contextualize clinical trial data and inform treatment decisions in urothelial cancer.

Shawna Kraft, PharmD, BCOP

Latest:

Dr Kraft on VEGF Inhibitor–Induced Hypertension in RCC

Shawna Kraft, PharmD, BCOP, discusses the incidence and mitigation of VEGF inhibitor–induced hypertension in patients with renal cell carcinoma (RCC).

American Oncology Network

Latest:

American Oncology Network Celebrates Momentous Five-Year Anniversary of Closing the Cancer Care Gap

American Oncology Network, one of the fastest-growing community oncology networks in the United States, proudly celebrated its fifth anniversary, commemorating a half-decade of excellence in advancing community oncology and driving value-based care initiatives to close the cancer care gap.

Sunil Sharma, MD

Latest:

Leveraging Immunotherapy in GI Malignancies: Looking to the Future

In this episode of OncChats: Leveraging Immunotherapy in GI Malignancies, experts discuss next steps for research, including vaccination strategies, personalized cellular therapies, and more.

Blase Polite, MD

Latest:

Incorporating ctDNA Into Routine Practice: Clinical Pearls

Advice to GI oncologists in the community on using ctDNA testing to detect minimal residual disease and inform treatment decisions in colorectal cancer.

Janine Joseph, MS, MBA

Janine Joseph, MS, MBA, is a senior research specialist at Roswell Park Comprehensive Cancer Center.

Latest:

Joseph on the Research Behind the Role of Exercise and Supportive Care in Myeloma

Janine Joseph, MS, MBA, discusses the current state of research and future directions for resistance training interventions in patients with multiple myeloma.

Krystal L. Cleven, MD, MS

Latest:

The Importance of Lung Cancer Screening in Individuals Exposed to the World Trade Center Disaster

Investigators evaluated risk factor–based guidelines and risk model–based strategies for lung cancer screening in World Trade Center–exposed responders.

UCSF Health

Latest:

UCSF Health Experts Spotlight Advances, Receive Recognition at National Hematology/Oncology Conference

Hematologists and oncologists from UCSF share research results and clinical guidance at the 2025 ASH Annual Meeting.

John Shen, MD

Latest:

Dr Shen on the Utility of ARX517 in mCRPC

John Shen, MD, discusses the utility of ARX517 in patients with metastatic castration-resistant prostate cancer.

Yago L. Nieto, MD, PhD

Latest:

Dr. Nieto on High-Dose Chemotherapy and ASCT in R/R Multiple Myeloma

Yago L. Nieto, MD, PhD, professor, Department of Stem Cell Transplantation and Cellular Therapy, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses findings from a phase 2 trial investigating panobinostat (Farydak), gemcitabine, busulfan, and melphalan plus autologous stem cell transplant (ASCT) in patients with high-risk or relapsed/refractory multiple myeloma.

Daniel King, MD, PhD

Latest:

Dr King on the Need for Less-Toxic Therapies in Advanced Gastrointestinal Cancers

Daniel King, MD, PhD, discusses the need to develop less-toxic regimens for advanced gastrointestinal cancers.

Timothy Cragin Wang, MD

Latest:

Dr. Wang on Challenges With Checkpoint Inhibitors in CRC

Timothy Cragin Wang, MD, discusses the lack of response to checkpoint inhibitors in colorectal cancer.

Hemant S. Murthy, MD

Latest:

Dr Murthy on the Use of CAR T-Cell Therapy in Elderly or Frail Patients With B-Cell Lymphomas

Hemant S. Murthy, MD, discusses the evolving use of CAR T-cell therapy for elderly or frail patients with relapsed/refractory B-cell lymphomas.

Selina M. Luger, MD, FRCPC

Latest:

Women in Oncology: Prioritization and Passionate Legacies

Selina M. Luger, MD, FRCPC, Gail J. Roboz, MD, and Wendy Stock, MD, discuss how being female affected their careers and share the scientific achievements they most want to be remembered for in the leukemia field.

Mina Lobbous, MD, MPH

Latest:

Dr Lobbous on Tucatinib Plus Trastuzumab/Capecitabine in HER2+ Breast Cancer Leptomeningeal Metastases

Mina Lobbous, MD, MPH, on tucatinib plus trastuzumab and capecitabine for leptomeningeal metastases from HER2-positive breast cancer.

Carlyn Rose Tan, MD

Han T. Cun, MD, MS

Latest:

Dr Cun on Molecular Classification in Endometrioid Endometrial Adenocarcinoma

Han T. Cun, MD, MS, discusses the findings from a retrospective comprehensive molecular classification of patients with grade 3 endometrioid endometrial adenocarcinoma.

Nina D'Abreo, MD,

Latest:

Dr D'Abreo on Patient Consideration When Choosing Treatments in HER2+ Breast Cancer

Nina D'Abreo, MD, discusses the importance of considering a patient’s medical history and preferences when deciding on a treatment course in HER2-positive breast cancer and highlights the important role of surgeons within breast cancer treatment.